The disease control rate was 92%, and the median progression-free survival was 13.7 months. Treatment with 177 Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and pembrolizumab appeared well ...

Patients with recurrent glioblastoma may derive a greater benefit from sacituzumab govitecan if they have high TROP2 expression.

Pre-operative fractionated stereotactic radiotherapy (FSRT) may produce better outcomes than post-operative FSRT in cancer patients with brain metastases.

The combination of ACT001 and radiotherapy elicited responses and was considered well tolerated in a phase 2 trial of pediatric patients with newly diagnosed DIPG.

The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii) for the treatment of adults with previously treated, unresectable or metastatic HER2-positive ...

Combination treatment with retifanlimab, bevacizumab, and hypofractionated radiotherapy — with or without epacadostat — ...

More research is needed to investigate the cause of the decline in cutaneous melanoma incidence among young patients, researchers say.

(HealthDay News) — President-elect Donald Trump says he will nominate Mehmet Oz, MD, to head the Centers for Medicare & Medicaid Services. In a statement, Trump said that Oz will “work closely with ...

Hospitals around the country are conserving critical intravenous fluid supplies to cope with a shortage that may last months.

Endometrial cancer (EC) is the sixth most prevalent cancer among women worldwide and the second most frequent gynecologic malignancy globally, after cervical cancer. However, in developed regions ...

Advanced endometrial cancer (EC), regardless of mismatch repair status, is often treated with a combination of carboplatin and paclitaxel (CP) chemotherapy over 6 cycles, followed by maintenance ...

Chronic lymphocytic leukemia (CLL) is a prevalent leukemia subtype, accounting for about 11% of hematologic malignancies. 1 CLL primarily affects older adults. Due to its often-slow progression ...